
Momentum and Meaning at the 2025 American Society of Hematology Meeting
CURE was on site at the 2025 ASH Annual Meeting, sharing expert conversations and patient-focused reporting that highlighted progress in blood cancer care.
The 2025 American Society of Hematology Annual Meeting in December in Orlando, Florida was filled with momentum, discovery and meaningful conversations, and CURE was on the ground capturing it all.
From the opening sessions, the excitement surrounding ASH 2025 was clear. Researchers, clinicians, patient advocates and industry leaders gathered to share new data and explore where blood cancer care is headed. Across disease areas, presentations highlighted emerging therapies, innovative combinations and early research that may influence future treatment approaches.
CURE’s coverage centered on translating science into insight. Throughout the meeting, the CURE team conducted on-site interviews with leading experts who helped break down complex findings and explain what new data could mean for patients with cancer and their caregivers. These conversations provided context around clinical trial results, potential side effects and ongoing questions that continue to shape research efforts.
Beyond the formal presentations, ASH 2025 was marked by a strong sense of collaboration and optimism. Hallway discussions, spontaneous interviews and exchanges between sessions reflected a community driven by shared goals: improving outcomes, expanding options and addressing unmet needs. Many experts spoke to the rapid pace of progress and the importance of continuing to push boundaries in hematology research.
Throughout the meeting, CURE highlighted key takeaways, emerging themes and expert perspectives to help audiences understand why these advances matter now and how they could shape care in the years ahead. By bringing together expert insight and patient-focused reporting, CURE helped bridge the gap between research and real-world impact.
ASH remains one of the most anticipated meetings in hematology, and 2025 delivered with impactful data and forward-looking conversations. CURE is proud to share these insights, helping patients with cancer, caregivers and the oncology community stay informed, inspired and connected to progress shaping the future of blood cancer care.
For more news on cancer updates, research and education,




